View Older Stories

Feb 28, 2026 12:15PM FDA approves Novo Nordisk's Sogroya for three new pediatric conditions

Feb 24, 2026 10:11AM BofA on Eli Lilly (LLY): 'Novo’s GLP-1 price update unlikely to ‘rock the boat’'

Feb 24, 2026 07:48AM Eli Lilly falls 2% on Novo Nordisk price cut plans

Feb 24, 2026 07:41AM Novo To Cut Ozempic, Wegovy's US List Prices By Up To 50% - WSJ

Feb 24, 2026 07:31AM Novo Nordisk To Cut Ozempic List Price By 34% - WSJ

Feb 24, 2026 03:44AM Kepler Cheuvreux Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 24, 2026 03:25AM Deutsche Bank Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 24, 2026 12:35AM JPMorgan Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Neutral

Feb 23, 2026 05:56AM Novo Nordisk's CagriSema fails to match tirzepatide in obesity trial

Feb 23, 2026 05:40AM Novo Nordisk (NVO) -13% after 'worst case' REDEFINE-4 readout; LLY +4%

Feb 23, 2026 05:10AM Novo Nordisk (NVO) call put ratio 1 call to 1 put as share price down before the bell

Feb 23, 2026 05:09AM Stocks expected to have increasing option volume: NVO USO XOM CVX SLV GDX DBX AKAM RNG MSTR TXRH LZ VNDA DPX

Feb 22, 2026 03:00PM Hims & Hers Health (HIMS) stock: Should you buy the dip after massive selloff?

Feb 17, 2026 08:59AM European Commission approves higher 7.2 mg dose of Novo Nordisk's Wegovy

Feb 12, 2026 07:12AM Jefferies lifts Novo Nordisk rating as downside risks crystallize

Feb 12, 2026 03:45AM Jefferies Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 11, 2026 06:41AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK400 at Deutsche Bank

Feb 9, 2026 10:15AM FDA flags Novo Nordisk Wegovy pill advertisement as misleading

Feb 9, 2026 09:21AM TD Cowen: 'Good News for Novo Nordisk (NVO), but Impact Uncertain'

Feb 9, 2026 08:26AM Hims and Hers (HIMS) PT Lowered to $20 at Leerink Partners

Feb 9, 2026 07:00AM Novo Nordisk sues Hims & Hers over compounded semaglutide products

Feb 9, 2026 06:53AM Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill

Feb 9, 2026 06:10AM Novo Nordisk (NVO) call put ratio 1.4 calls to 1 put into share price up before the bell

Feb 9, 2026 04:45AM Hims & Hers Health (HIMS) said to stop offering weight loss pill

Feb 6, 2026 04:51PM FDA moves to restrict copycat GLP-1 weight loss drugs

Feb 6, 2026 07:58AM Hims & Hers stock falls after FDA warns against illegal copycat drugs

Feb 6, 2026 06:04AM TD Cowen Reiterates Hold Rating on Hims and Hers (HIMS)

Feb 6, 2026 05:11AM Novo shares rebound as FDA vows crackdown on weight-loss drug copies

Feb 5, 2026 12:35PM Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'

Feb 5, 2026 10:46AM Novo Nordisk threatens legal action over Hims & Hers semaglutide pill

Feb 5, 2026 10:25AM Leerink: 'there is no reason why HIMS shouldn't evaluate these launches for every subsequent weight loss product'

Feb 5, 2026 10:24AM Wolfe Research on Eli Lilly (LLY): 'we question the legality of HIMS' ability to market an oral semaglutide'

Feb 5, 2026 10:10AM Wells Fargo on Eli Lilly (LLY): 'Compounders Strike Again, but We See Little Risk to Near-Term Growth'

Feb 5, 2026 09:58AM BMO Capital: 'Novo Mgmt Meetings Highlight Deep Strategic Challenges'

Feb 5, 2026 09:14AM Novo Nordisk (NVO) PT Lowered to $45 at BMO Capital Following 'Soft' Guide

Feb 5, 2026 09:08AM Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall

Feb 5, 2026 09:01AM Hims & Hers adds compounded semaglutide pills starting at $49 monthly

Feb 5, 2026 08:52AM Hims & Hers Health (HIMS) launches a copy of Wegovy pill at $49/month

Feb 4, 2026 09:42AM BMO Capital on Novo Nordisk: 'Expect NVO shares to remain pressured today'

Feb 3, 2026 12:22PM Novo Nordisk shares plunge amid lower 2026 sales outlook

Feb 3, 2026 12:05PM Novo Nordisk (NVO) Tops Q4 EPS by 10c; Lowers Outlook

Feb 3, 2026 11:46AM Eli Lilly & Co. (LLY) sees volatility amid Novo's warning

Feb 3, 2026 11:38AM Novo Nordisk reports 2025 sales growth, cuts 2026 outlook

Feb 3, 2026 11:36AM Novo Nordisk (NVO) Halted, News Pending

Feb 3, 2026 09:33AM TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO)

Feb 2, 2026 10:44AM Novo Nordisk's CagriSema shows superior diabetes control in phase 3 trial

Jan 28, 2026 06:21AM Walmart raises pharmacy technician wages as it expands healthcare services

Jan 27, 2026 10:52AM Citi initiates coverage of European pharma stocks; AstraZeneca 'best in class'

Jan 26, 2026 09:36AM Novo Nordisk (NVO) PT Raised to $57 at BMO Capital

Jan 23, 2026 06:00PM This stock is Kepler's top pick in the European pharma sector

View Older Stories